Division of Infectious Diseases

Fellows Awards & Publications

Major Awards Received by Einstein Infectious Diseases Fellows (1995–2010)

  • David Beenhouwer: NIH Physician Scientist K Award
  • Marta Feldmesser: NIH Physician Scientist K Award
  • Michelle Floris-Moore: NIH Minority Fellowship NIAID; Einstein Clinical Investigator Award
  • Aharona Freedman: Aaron Diamond Scholarship; NIH Physician Scientist K Award
  • Bettina Fries: Mycology IDSA Award 1998-2000 (declined due to overlap); Howard Hughes Postdoctoral Award 1998-2001; NIH Physician Scientist K Award
  • Michael Glickman: NIH Physician Scientist K Award
  • David Goldman: NIH Physician Scientist K Award
  • Howard Andrea NIH Clinical Physician Scientist award
  • Joshua Nosanchuk: Mycology IDSA Award; NIH Physician Scientist K Award
  • Paul Riska: Aaron Diamond Scholarship; NIH Physician Scientist K Award
  • Sandra Sallustio: Burroughs Wellcome
  • JoAnn Tufariello: NIH Physician Scientist K Award
  • Craig Werner: NIH Physician Scientist K Award
  • Dawn Fishbein: NIH Physician Scientist K Award; Einstein Clinical Investigator Award
  • Morad Hassani: NIH Physician Scientist K Award
  • Mahalia Desruisseaux: Colin Powell I.D.S.A. Minority Fellowship Award
  • Rahki Kohli NIH Physician Scientist award (post fellowship)
  • Anjali Sharma A award (post fellowship)

Fellows Who Completed Master of Science or Master of Public Health Programs  

  • 2010 Anna Kaltas
  • 2008 Zainab Malik (Pediatrics)
  • 2007 Melissa Wiener
  • 2005 Rahki Kohli, Anjali Sharma
  • 2004 Dawn Fishbein
  • 2002 Michelle Floris-Moore
  • 2001 Margaret Tawadrous
  • 2000 Andrea Howard
  • 1998 Gianna Zucottii MPH (Columbia University)

Junior Faculty who Graduated with Master of Science 

  • 2009 Jacqueline Achkar, Rebekka Madan (Pediatrics)
     

Publications

Publications are listed in reverse chronological order and limited to articles co-authored by fellows and work completed as fellows in the Division of Infectious Diseases.

2009 

Douvoyiannis, M., Kalyoussef, S., Philip, G., Mayers, MM. Chryseobacterium indologenes bacteremia in an infant. Int J Infect Dis. Sept 2009.

Douvoyiannis, M., Litman, N. Goldman, DL. Neurologic Manifestations Associated with Parvovirus B19 Infection.CID 2009:Jun 15;48(12):1713-23.

Douvoyiannis, M., Litman, N., Dulau,A., Ilowite, N. Panniculitis, infection, and dermatomyositis: case and literature review. Clin Rheumatol (2009) Jun,28 (Suppl 1):S57-S63.

Douvoyiannis, M., Litman, N. Acute encephalopathy and multi-organ involvement with rhabdomyolysis during primary HIV infection. Int J Infect Dis. 2009. Sept;13(5). E299-304.

Douvoyiannis, M., Bordy, L., Fakioglu, E. An infant with diffuse lung masses.  Clin Pediatr (Phila). 2009 Jul;48(6):686-9.

Mwakingwe A, Ting LM, Hochman S, Chen J, Sinnis P, Kim K. Noninvasive real-time monitoring of liver-stage development of bioluminescent Plasmodium parasites.  J Infect Dis. 2009 Nov 1;200(9):1470-8.

Hochman S, Kim K. The Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study. Interdiscip Perspect Infect Dis. 2009;2009:617954.

Sandkovsky U, Mihu MR, Adeyeye A, De Forest PM, Nosanchuk JD.Iatrogenic meningitis in an obstetric patient after combined spinal-epidural analgesia: case report and review of the literature.South Med J. 2009 Mar;102(3):287-90.

Madan RP, Campbell AL, Shust GF, Kahn AR, Wistinghausen B, Posada R, Kerkar N, Shneider BL, Emre S, Herold BC.A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.Transplantation. 2009 May 15;87(9):1318-24

 2008 

Chandwani, A., Shuter, J. Lopinavir/ritonavir in the treatment of HIV-1 infection: a review. Ther Clin Risk Manag. Oct. 2008;4(5):1023-1033

Chandwani, A., Shuter, J. Lopinavir/ritonavir in the treatment of HIV-1 infection: a review. Ther Clin Risk Manag. Oct. 2008;4(5):1023-1033

Douvoyiannis, M., Litman, N. Goldman, DL. A traveler with rash and thrombocytopenia. Clin Pediatr (Phila). 2009 Jun;48(5):568-71.

Chandwani, A., Shuter, J. Lopinavir/ritonavir in the treatment of HIV-1 infection: a review. Ther Clin Risk Manag. Oct. 2008;4(5):1023-1033

Douvoyiannis, M., Goldman, DL, Abbott IR 3rd, Litman, N.  Posterior fossa dermoid cyst with sinus tract and meningitis in a toddler. Pediatr Neurol. 2008 Jul; 39(1):63-6.

Douvoyiannis M, Belamarich PF, Litman N. Parotitis and kawasaki disease in a child with Noonan syndrome. Pediatr Infect Dis J. 2008 Jan;27(1):89-90.

Baum SG, Kaltsas A. Guideline tyranny: primum non nocere.Clin Infect Dis. 2008 Jun 15;46(12):1879-80.

Douvoyiannis, M., Litman, N. Goldman, DL. A traveler with rash and thrombocytopenia. Clin Pediatr (Phila). 2009 Jun;48(5):568-71.

Douvoyiannis, M., Litman, N. Goldman, DL. A traveler with rash and thrombocytopenia. Clin Pediatr (Phila). 2009 Jun;48(5):568-71.

Ritter M, Goldman DL. Pharmacotherapy of cryptococcosis.Expert Opin Pharmacother. 2009 Oct;10(15):2433-43.

2007 

Al-Sayyed B, Piperdi S, Yuan X, Li A, Besra GS, Jacobs WR Jr, Casadevall A, Glatman-Freedman A.  Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.  Tuberculosis (Ednib). 2007 Nov;87(6):489-97.

2006 

Lemos-Filho L, Fries B. An encounter with rabies in New York City. Clin Infect Dis. 2006 Dec 1; 43(11):1492-3.

Tufariello JM, Mi K, Xu J, Manabe YC, Kesavan AK, Drumm J, Tanaka K, Jacobs WR Jr, Chan J. Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. Infect Immun. 2006 May; 74(5):2985-95.

Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, Koch C, Tufariello J, Flynn J, Chan J. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol. 2006 Feb; 8(2):218-32.

Floris-Moore M, Howard AA, Lo Y, Arnsten JH, Santoro N, Schoenbaum EE. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med. 2006 Oct; 7(7):421-30.

Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N, Klein RS. Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med. 2006 Sep; 7(6):389-96.

Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE. HIV infection and bone mineral density in middle-aged women. Clin Infect Dis. 2006 Apr 1; 42(7):1014-20.

Evering T, Weiss LM. The immunology of parasite infections in immunocompromised hosts. Parasite Immunol. 2006 Nov; 28(11):549-65.

Derrick SC, Evering TH, Sambandamurthy VK, Jalapathy KV, Hsu T, Chen B, Chen M, Russell RG, Junqueira-Kipnis AP, Orme IM, Porcelli SA, Jacobs WR Jr, Morris SL. Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine. Immunology. 2006 Oct 31.

Fishbein DA, Lo Y, Netski D, Thomas DL, Klein RS. Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. J Acquir Immune Defic Syndr. 2006 Apr 1; 41(4):471-6.

Dev D, Lo Y, Ho GY, Burk RD, Klein RS. Incidence of and risk factors for genital human papillomavirus infection in women drug users. J Acquir Immune Defic Syndr. 2006 Apr 1; 41(4):527-9.

Kohli R, Lo Y, Homel P, Flanigan TP, Gardner LI, Howard AA, Rompalo AM, Moskaleva G, Schuman P, Schoenbaum EE; HER Study Group. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis. 2006 Jul 1; 43(1):90-8.

Kohli R, Klein RS, Schoenbaum EE, Anastos K, Minkoff H, Sacks HS. Aging and HIV infection. J Urban Health. 2006 Jan; 83(1):31-42.

Dadachova E, Patel MC, Toussi S, Apostolidis C, Morgenstern A, Brechbiel MW, Gorny MK, Zolla-Pazner S, Casadevall A, Goldstein H. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med. 2006 Nov; 3(11):e427.

Malik ZA, Litman N. The penicillins. Pediatr Rev. 2006 Dec; 27(12):471-3.

Malik ZA, Litman N. Ampicillin and amoxicillin. Pediatr Rev. 2006 Nov; 27(11):434-6.

Desruisseaux MS, Nagajyothi, Trujillo ME, Tanowitz HB, Scherer PE. The Adipocyte, Adipose Tissue and Infectious Disease. Infect Immun. 2006 Nov 21;

Bouzahzah B, Nagajyothi F, Desruisseaux MS, Krishnamachary M, Factor SM, Cohen AW, Lisanti MP, Petkova SB, Pestell RG, Wittner M, Mukherjee S, Weiss LM, Jelicks LA, Albanese C, Tanowitz HB. Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infection. Cell Cycle. 2006 Oct; 5(20):2396-400.

Machado FS, Desruisseaux MS, Nagajyothi, Kennan RP, Hetherington HP, Wittner M, Weiss LM, Lee SC, Scherer PE, Tsuji M, Tanowitz HB. Endothelin in a murine model of cerebral malaria. Exp Biol Med (Maywood). 2006 Jun; 231(6):1176-81.

Hassan GS, Mukherjee S, Nagajyothi F, Weiss LM, Petkova SB, de Almeida CJ, Huang H, Desruisseaux MS, Bouzahzah B, Pestell RG, Albanese C, Christ GJ, Lisanti MP, Tanowitz HB. Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun. 2006 Jan; 74(1):152-9.

Nagajyothi F, Desruisseaux M, Bouzahzah B, Weiss LM, Andrade Ddos S, Factor SM, Scherer PE, Albanese C, Lisanti MP, Tanowitz HB. Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle. 2006 Jan; 5(1):107-12.

Jalali Z, Ng L, Singh N, Pirofski LA. Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation. Clin Vaccine Immunol. 2006 Jul; 13(7):740-6.

Vianna LE, Lo Y, Klein RS. Serum prostate-specific antigen levels in older men with or at risk of HIV infection. HIV Med. 2006 Oct; 7(7):471-6.

Cheung C, Guo Y, Gialanella P, Feldmesser M. Development of candidemia on caspofungin therapy: a case report. 2006 Dec; 34(6):345-8.

2005 

Schoenbaum EE, Hartel D, Lo Y, Howard AA, Floris-Moore M, Arnsten JH, Santoro N. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis. 2005 Nov 15; 41(10):1517-24.

Miller SA, Santoro N, Lo Y, Howard AA, Arnsten JH, Floris-Moore M, Moskaleva G, Schoenbaum EE. Menopause symptoms in HIV-infected and drug-using women. Menopause. 2005 May-Jun; 12(3):348-56.

Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y, Schoenbaum EE. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis. 2005 May 15; 40(10):1492-9.

Patel MC, Levi MH, Mahadevi P, Nana M, Merav AD, Robbins N. L. micdadei PVE successfully treated with levofloxacin/valve replacement: case report and review of the literature. J Infect. 2005 Dec; 51(5):e265-8.

Kennan RP, Machado FS, Lee SC, Desruisseaux MS, Wittner M, Tsuji M, Tanowitz HB. Reduced cerebral blood flow and N-acetyl aspartate in a murine model of cerebral malaria. Parasitol Res. 2005 Jul; 96(5):302-7.

Purkayastha T, Wasi F, Shuter J. Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic. AIDS Patient Care STDS. 2005 Dec; 19(12):785-93.

Kohli R, Lo Y, Howard AA, Buono D, Floris-Moore M, Klein RS, Schoenbaum EE. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005 Sep 15; 41(6):864-72.

2004 

Currie BP, Lemos-Filho L. Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2004 Nov; 48(11):4427-9.

Tufariello JM, Jacobs WR Jr, Chan J. Individual Mycobacterium tuberculosis resuscitation-promoting factor homologues are dispensable for growth in vitro and in vivo. Infect Immun. 2004 Jan; 72(1):515-26.

Glatman-Freedman A, Casadevall A, Dai Z, Jacobs WR Jr, Li A, Morris SL, Navoa JA, Piperdi S, Robbins JB, Schneerson R, Schwebach JR, Shapiro M. Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. J Clin Microbiol. 2004 Jul; 42(7):3225-31.

Kohli R, Jenny-Avital E. Risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004 Aug 15; 39(4):599-600; author reply 600-1.

Hassani M, Patel MC, Pirofski LA. Vaccines for the prevention of diseases caused by potential bioweapons. Clin Immunol. 2004 Apr; 111(1):1-15.

Fishbein DA, Lo Y, Reinus JF, Gourevitch MN, Klein RS. Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr. 2004 Nov 1; 37(3):1367-75.

Vaidian AK, Weiss LM, Tanowitz HB. Kinetoplastid Biol Dis. Chagas' disease and AIDS. 2004 May 13; 3(1):2.

2003 

Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis. 2003 Sep; 3(9):578-90.

Mukherjee S, Huang H, Weiss LM, Costa S, Scharfstein J, Tanowitz HB. Role of vasoactive mediators in the pathogenesis of Chagas' disease. Front Biosci. 2003 May 1; 8:e410-9.

Levi MH, Bartell J, Gandolfo L, Smole SC, Costa SF, Weiss LM, Johnson LK, Osterhout G, Herbst LH. Characterization of Mycobacterium montefiorense sp. nov., a novel pathogenic Mycobacterium from moray eels that is related to Mycobacterium triplex. J Clin Microbiol. 2003 May; 41(5):2147-52.

Floris-Moore M, Lo Y, Klein RS, Budner N, Gourevitch MN, Moskaleva G, Schoenbaum EE. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003 Nov 1; 34(3):331-7.

Floris-Moore MA, Amodio-Groton MI, Catalano MT. Adverse reactions to trimethoprim/sulfamethoxazole in AIDS. Ann Pharmacother. 2003 Dec; 37(12):1810-3.

Navoa JA, Laal S, Pirofski LA, McLean GR, Dai Z, Robbins JB, Schneerson R, Casadevall A, Glatman-Freedman A. Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clin Diagn Lab Immunol. 2003 Jan; 10(1):88-94.

Subramaniam KS, Segal R, Lyles RH, Rodriguez-Barradas MC, Pirofski LA. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy. J Infect Dis. 2003 Mar 1; 187(5):758-68.

Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr. 2003 Jul 1; 33(3):356-64.

Kojaoghlanian T, Flomenberg P, Horwitz MS. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol. 2003 May-Jun; 13(3):155-71.

Dahlseid JN, Lew-Smith J, Lelivelt MJ, Enomoto S, Ford A, Desruisseaux M, McClellan M, Lue N, Culbertson MR, Berman J. mRNAs encoding telomerase components and regulators are controlled by UPF genes in Saccharomyces cerevisiae. Eukaryot Cell. 2003 Feb; 2(1):134-42.

Wasi F, Shuter J. Primary bacterial infection of the myocardium. Front Biosci. 2003 May 1; 8:s228-31.

2002 

Demas PA, Webber MP, Schoenbaum EE, Weedon J, McWayne J, Enriquez E, Bamji M, Lambert G, Thea DM. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study. Pediatrics. 2002 Sep; 110(3):e35.

Schoenbaum EE, Lo Y, Floris-Moore M. Predictors of hospitalization for HIV-positive women and men drug users, 1996-2000. Public Health Rep. 2002; 117 Suppl 1:S60-6.

Tarr PE, Contursi C, Roncarati R, Noviello C, Ghersi E, Scheinfeld MH, Zambrano N, Russo T, D'Adamio L. Evidence for a role of the nerve growth factor receptor TrkA in tyrosine phosphorylation and processing of beta-APP. Biochem Biophys Res Commun. 2002 Jul 12; 295(2):324-9.

Tarr PE, Roncarati R, Pelicci G, Pelicci PG, D'Adamio L. Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J Biol Chem. 2002 May 10;277(19):16798-804.

Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD. Administration of monoclonal antibodies to Cryptococcus neoformans protects mice deficient in complement component C3. Infect Immun. 70:2598-2604.

Evering T, Kaswan D, Minamoto GY. Management of the Patient with HIV infection. In Rakel RE, Bope ET (eds): Conn's Current Therapy. Elsevier Science/W.B. Saunders Co., Philadelphia, Pa., 2003; 55th edition: 49-63.

Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002; 17:377-381.

Howard AA, Klein RS, Schoenbaum EE, Gourevitch MN. Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis 2002; 35:1183-90.

Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE, for the HER Study Group. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002; 16:2175-82.

Kojaoghlanian T, Horwitz MS. Adenoviruses. In SL Gorbach, JG Bartlett and NR Blacklow (eds.): Infectious Diseases. Lippincott, Williams, and Wilkins, Philadelphia, Pa., 2003; 3rd edition: 1894-1904.

Park JC, Buono D, Smith DK, Peipert J, Sobel J, Rompalo A, Klein RS, for the HIV Epidemiology Research Study Group. Urinary tract infections in women with or at risk for HIV infection. Am J Obstet Gynecol. 2002 Sep; 187(3):581-8.

Sharma A, Mong MS, Minamoto GY. Enterococcus faecalis: an unusual cause of meningitis in HIV-infected patients. The AIDS Reader. 2002 Dec; 12(12):540-2.

Bardarov S, Bardarov Jr S, Pavelka Jr MS, Sambandamurthy V, Larsen M, Tufariello J, Chan, J, Harfull G, Jacobs WR. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis, BCG and M. smegmatis. Microbiology. 2002:148; 3007-3017.

Huang H, Werner C, Weiss LM, Wittner M, Orr GA. Molecular cloning and expression of the catalytic subunit of protein kinase from Trypanosoma cruzi. Int. J. Parasitol. 2002; 32:1107-15.

2001 

Webber MP, Demas P, Enriquez E, Shanker R, Oleszko W, Beatrice ST, Schoenbaum EE. Pilot study of expedited HIV-1 testing of women in labor at an inner-city hospital in New York City. Am J Perinatol. 2001; 18(1):49-57.

Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD. Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun. 2001:39:3365-3367.

Herbst LH, Costa SF, Weiss LM, Johnson LK, Bartell J, Davis R, Walsh M, Levi M. Granulomatous skin lesions in moray eels caused by a novel Mycobacterium species related to Mycobacterium triplex. Infect Immun. 2001 Jul;69(7):4639-46.

Weiss LM, Costa SF, Zhang H. Microsporidian methionine aminopeptidase type 2. J Eukaryot Microbiol. 2001;Suppl:88S-90S.

Fries BC, Tarborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 2001;108:1639-1648.

Glickman MS, Jacobs WR. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell. 2001;104:477-85.

Glickman MS, Cahill, SM, Jacobs WR. The Mycobacterium tuberculosis emaA2 gene encodes a mycolic acid trans-cyclopropane synthetase. J Biol Chem. 2001;276:2228-33.

Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Clin Infect Dis. 2001;33:1417-1423.

Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C, Smith DK. Antiretroviral regimen complexity, self-reported adherence and HIV patients' understanding of their regimens: a survey of women in the HER Study. J Acquir Immune Defic Syndr. 2001;28:124-131.

Nosanchuk JD, Ovalle R, Casadevall A. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice following systemic infection. J Infect Dis. 2001;183:1093-1099.

Gomez BL, Nosanchuk JD, Diez S, Youngchim S, Aisen P, Cano LE, Restrepo A, Casadevall A, and Hamilton AJ. Detection of melanin-like pigments in the dimorphic fungal pathogen Paracoccidioides brasiliensis in vitro and during infection. Infect Immun. 2001:69:5760-5767.

Rosas AL, Nosanchuk J, Casadevall A. Passive immunization with melanin-binding monoclonal antibodies prolongs survival in mice with lethal Cryptococcus neoformans infection. Infect Immun. 2001:69:3410-3412.

Segal RE, Minamoto GY. Therapy for fungal infections in leukemia, in Markman M, Scheinberg DA (eds.): Leukemia, Current Oncology Reports. Philadelphia, Current Science Inc., 2001; 201-8.

Szilak I, Marty F, Helft J, Soeiro R. Neurosyphilis presenting as herpes simplex encephalitis. Clin Infect Dis 2001;32:1108-9.

2000 

Chang Q, Abadi J, Alpert P, Pirofski LA. Pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus(HIV)-uninfected but not HIV-infected persons. J Infect Dis. 2000 Apr;181(4):1313-21.

Costa SF, Weiss LM. Drug treatment of microsporidiosis. Drug Resist Update 2000 Dec;3(6):384-99.

Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun. 2000 Jul;68(7):4225-37.

Feldmesser M, Rivera J, Kress Y, Kozel TR, Casadevall A. Antibody interactions with the capsule of Cryptococcus neoformans. Infect Immun. 2000 Jun;68(6):3642-50.

Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun. 2000 May;68(5):2845-53.

Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol. 1999 Jan;19(1):745-50.

Nosanchuk JD, Shoham S, Fries BC, Shapiro DS, Levitz SM, Casadevall A. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000 Feb 1;132(3):205-8.

Glatman-Freedman A, Mednick AJ, Lendvai N, Casadevall A. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M. Infect Immun. 2000;68:335-341.

Glickman MS, Cox JS, Jacobs WR Jr. A novel mycolic acid cyclopropane synthetase is required for coding, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell. 2000 Apr;5(4):717-27.

Goldman DL, Lee SC, Mednick AJ, Montella L, Casadevall A. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect Immun. 2000 Feb;68(2):832-8.

Lukashok SA, Tarassishin L, Li Y, Horwitz MS. An adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis complexes with dyne in and a small GTPase. J Virol. 2000 May;74(10):4705-9.

Casadevall A, Rosas AL, Nosanchuk JD. Melanin and virulence in Cryptococcus neoformans. Current Opinion in Microbiology 2000;3:354-358.

Nosanchuk JD, Rosas AL, Lee SC, Casadevall A. Melanization of Cryptococcus neoformans in human brain tissue. Lancet. 2000 Jun 10;355(9220):2049-50.

Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun. 2000 May;68(5):2845-53.

Nosanchuk JD, Shoham S, Fries BC, Shapiro DS, Levitz SM, Casadevall A. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000 Feb 1;132(3):205-8.

Orr GA, Werner C, Xy J, Bennett M, Weiss LM, Takvorkan P, Tanowitz HB, Wittner M. Identification of novel serine/threonine protein phosphatases in Trypanosoma cruzi: a potential role in control of cytokinesis and morphology. Infect Immun. 2000:1350-8.

Russell N, Corvalan JR, Gallo ML, Davis CG, Pirofski L. Production of protective human anti-pneumococcal antibodies by transgenic mice with human immunoglobulin loci. Infect Immun. 2000;68:1820-1826.

Shah FS, Curr KA, Hamburgh ME, Parniak MA, Mitsuya H, Arnez JG, Prasad VR. Differential influence of nucleoside analog-resistance mutations K65R and L74V on the overall mutation rate and error specificity of human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem. 2000 Sep 1;275(35):27037-44.

Szilak I, Minamoto GY. West Nile viral encephalitis in an HIV-positive woman in New York. N Engl J Med 2000;342:59-60.

Tufariello JM, Kaleya RN, Klein RS. Group A streptococcal appendicitis in a patient with AIDS. Diagn Microbiol Infect Dis. 2000 Nov;38(3):171-172.

Zimhony O, Cox JS, Welch JT, Vicheze C., Jacobs WR. Pyrazinamide inhibits the eukaryotic-like fatty acid synthase I (FASI) of Mycobacterium tuberculosis. Nat Med. 2000:6;1043-7.

1999 

Abadi J, Nachman S, Kressel AB, Pirofski L. Cryptococcosis in children with AIDS. Clin Infect Dis. 1999 Feb;28(2):309-13.

Abadi J, Nachman S, Kressel AB, Pirofski L. Antibodies reactive with cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without HIV infection. J Inf Dis. 1999;180:915-919.

Feldmesser M, Gordon G, Robbins N. Lactobacillus endocarditis. Heart Dis. 1999;1:208-209.

Fries BC, Goldman DL, Cherniak R, Ju R, Casadevall A. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun. 1999 Nov;67(11):6076-83.

Gareca M, Klein RS. Yersinia enterocolitica peritonitis in a patient on chronic ambulatory peritoneal dialysis. Inf Dis Clin Pract 1999;8(3):162-163.

Chen LC, Goldman DL, Doering TL, Pirofski L, Casadevall A. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect Immun. 1999 May;67(5):2218-24.

Abadi J, Nachman S, Kressel AB, Pirofski L. Cryptococcosis in children with AIDS. Clin Infect Dis. 1999 Feb;28(2):309-13.

Nosanchuk JD, Rudolph J, Rosas AL, Casadevall A. Evidence that Cryptococcus neoformans is melanized in pigeon excreta: implications for pathogenesis. Infect Immun. 1999 Oct;67(10):5477-9.

Doering TL, Nosanchuk JD, Roberts WK, Casadevall A. Melanin as a potential cryptococcal defense against microbicidal proteins. Med Mycol. 1999 Jun;37(3):175-81.

Nosanchuk JD, Casadevall A. Separated at birth. N Engl J Med. 1999 Feb 4;340(5):395.

Nosanchuk JD, Cleare W, Franzot SP, Casadevall A. Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations. Antimicrob Agents Chemother. 1999 Feb;43(2):233-9.

Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol. 1999 Jan;19(1):745-50.

Riska PF, Su Y, Bardarov S, Freundlich L, Sarkis G, Hatfull G, Carriere C, Kumar V, Chan J, Jacobs WR Jr. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol. 1999 Apr;37(4):1144-9.

Shuter J, Alpert PL, DeShaw MG, Greenberg B, Klein RS. Gender differences in HIV risk behaviors in an adult emergency department in New York City. J Urban Health. 1999 Jun;76(2):237-246.

Way SS, Sallustio S, Magliozzo RS, Goldberg MB. Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence. J Bacteriol. 1999 Feb;181(4):1229-1237.

Zimhony O, Stein D. Saquinavir-induced hypoglycemia in type 2 diabetes. Ann Intern Med. 1999:131:980.

1998 

Abadi J, Friedman J, Mageed RA, Jefferis R, Rodriguez-Barradas MC, Pirofski L. Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of V(H)3 gene segment usage. J Infect Dis. 1998 Sep;178(3):707-16.

Coyle C, Kent M, Tanowitz HB, Wittner M, Weiss LM. TNP-470 is an effective antimicrosporidial agent. J Infect Dis. 1998 Feb;177(2):515-8.

Rivera J, Feldmesser M, Cammer M, Casadevall A. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect Immun. 1998 Oct;66(10):5027-30.

Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46.

Feldmesser M, Kress Y, Casadevall A. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans. J Infect Dis. 1998 Jun;177(6):1639-46.

Dong F, Feldmesser M, Casadevall A, Rubin CS. Molecular characterization of a cDNA that encodes six isoforms of a novel murine A kinase anchor protein. J Biol Chem. 1998 Mar 13;273(11):6533-41.

Feldmesser M, Casadevall A. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection. Front Biosci. 1998 Feb 1;3:D136-51.

Goldman DL, Fries BC, Franzot SP, Montella L, Casadevall A. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14967-72.

Fries BC, Casadevall A. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis. 1998 Dec;178(6):1761-6.

Franzot SP, Fries BC, Cleare W, Casadevall A. Genetic relationship between Cryptococcus neoformans var. neoformans strains of serotypes A and D. J Clin Microbiol. 1998 Aug;36(8):2200-4.

Glatman-Freedman A, Casadevall A. Serum therapy for tuberculosis revisited: reppraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev. 1998;11:514-532.

Teitelbaum R, Glatman-Freedman A, Chen B, Robbins JB, Unaunue E, Casadevall A, Bloom BR. A mAb recognizing the surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A. 1998;95:15688-15693.

Goldman DL, Fries BC, Franzot SP, Montella L, Casadevall A. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14967-72.

Lendvai N, Casadevall A, Liang Z, Goldman DL, Mukherjee J, Zuckier L. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide. J Infect Dis. 1998 Jun;177(6):1647-59.

Holbrook KA, Lowy FD. Beta-lactam antibiotics. Cancer Invest. 1998;16(6):405-12.

Lukashok SA, Horwitz MS. New perspectives in adenoviruses. Curr Clin Top Infect Dis. 1998;18:286-305.

Munsiff SS, Alpert PL, Gourevitch MN, Chang CJ, Klein RS. A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):361-6.

Nosanchuk JD, Rosas AL, Casadevall A. The antibody response to fungal melanin in mice. J Immunol. 1998 Jun 15;160(12):6026-31.

Shah S, Tanowitz HB, Wittner M. The ethnic minority traveler. Infect Dis Clin North Am. 1998 Jun;12(2):523-41.

1997 

Abadi J, Zhong Z, Dobroszycki J, Pirofski L. Fc gamma RIIa polymorphism in human immunodeficiency virus-infected children with invasive pneumococcal disease. Pediatr Res. 1997 Sep;42(3):259-62.

Dobroszycki J, Abadi J, Lambert G, Beenhouwer DO, Truong TH, Wiznia AA. Testicular abscess due to Streptococcus pneumoniae in an infant with human immunodeficiency virus infection. Clin Infect Dis. 1997 Jan;24(1):84-5.

Steinhauer J, Agha R, Pham T, Varga AW, Goldberg MB. The unipolar Shigella surface protein IcsA is targeted directly to the bacterial old pole: IcsP cleavage of IcsA occurs over the entire bacterial surface. Mol Microbiol. 1999 Apr;32(2):367-77.

Alpert PL, Munsiff SS, Gourevitch MN, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis. 1997 Apr;24(4):661-668.

Feldmesser M, Casadevall A, Kress Y, Spira G, Orlofsky A. Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infect Immun. 1997 May;65(5):1899-907.

Feldmesser M, Casadevall A. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J Immunol. 1997 Jan 15;158(2):790-9.

Glickman M, Klein RS. Acute epiglottitis in an adult due to Pasteurella multocida. Emerging Infect Dis. 1997 Jul-Sep;3(3):408-409.

Goldman DL, Casadevall A, Zuckier LS. Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy. J Med Vet Mycol. 1997 Jul-Aug;35(4):271-8.

Holbrook KA, Klein RS, Hartel D, Elliott DA, Barsky TB, Rothschild LH, Lowy FD. Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):301-6.

Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis. 1997 Apr;24(4):661-8.

Nosanchuk JD, Casadevall A. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun. 1997 May;65(5):1836-41.

Carriere C, Riska PF, Zimhony O, Kriakov J, Bardarov S, Burns J, Chan J, Jacobs WR Jr. Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J Clin Microbiol. 1997 Dec;35(12):3232-9.

Riska PF, Jacobs WR Jr, Bloom BR, McKitrick J, Chan J. Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J Clin Microbiol. 1997 Dec;35(12):3225-31.

Shere KD, Sallustio S, Manessis A, D'Aversa TG, Goldberg MB. Disruption of IcsP, the major Shigella protease that cleaves IcsA, accelerates actin-based motility. Mol Microbiol. 1997 Aug;25(3):451-62.

Shuter J, Alpert PL, DeShaw MG, Greenberg B, Klein RS. Rates of and factors associated with self-reported prior HIV testing among adult medical patients in an inner city emergency department in the Bronx, New York City. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):61-66.

Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam RA, Bloom BR, Hatfull GF, Jacobs WR Jr. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10961-6.

1996 

Alpert PL, Shuter J, DeShaw MG, Webber MP, Klein RS. Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med 1996. Aug;28(2):159-164.

Beenhouwer DO, Nosanchuk JD, Zingman BS. Recurrent meningitis in a 38 year old man with cirrhosis. Int J Infect Dis 1996;198-101.

Tanowitz HB, Simon D, Weiss LM, Noyer C, Coyle C, Wittner M. Gastrointestinal manifestations. Med Clin North Am. 1996 Nov;80(6):1395-414.

Coyle CM, Wittner M, Kotler DP, Noyer C, Orenstein JM, Tanowitz HB, Weiss LM. Prevalence of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon (Septata) intestinalis among patients with AIDS-related diarrhea: determination by polymerase chain reaction to the microsporidian small-subunit rRNA gene. Clin Infect Dis. 1996 Nov;23(5):1002-6.

Coyle C, Bacchi C, Yarlett N, Tanowitz HB, Wittner M, Weiss LM. Polyamine metabolism as a therapeutic target for Microsporidia. J Eukaryot Microbiol. 1996 Sep-Oct;43(5):96S.

Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum cryptococcal antigen in patients with AIDS. Clin Infect Dis. 1996 Oct;23(4):827-30.

Mukherjee S, Feldmesser M, Casadevall A. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J Infect Dis. 1996 May;173(5):1222-31.

Feldmesser M, Mukherjee J, Casadevall A. Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro. J Antimicrob Chemother. 1996 Mar;37(3):617-22.

Fries BC, Chen F, Currie BP, Casadevall A. Karyotype instability in Cryptococcus neoformans infection. J Clin Microbiol. 1996 Jun;34(6):1531-4.

Goldman DL, Casadevall A, Cho Y, Lee SC. Cryptococcus neoformans meningitis in the rat. Lab Invest. 1996 Dec;75(6):759-70.

Goldman D, Cho Y, Zhao M, Casadevall A, Lee SC. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas. Am J Pathol. 1996 Apr;148(4):1275-82.

Parsons RE, Sanchez LA, Marin ML, Holbrook KA, Faries PL, Suggs WD, Lyon RT, Lowy FD, Veith FJ. Comparison of endovascular and conventional vascular prostheses in an experimental infection model. J Vasc Surg. 1996 Dec;24(6):920-5; discussion 925-6.

Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM. Atovaquone in the treatment of Babesia microti infections in hamsters. Am J Trop Med Hyg. 1996 Aug;55(2):219-22.

Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, Munsiff SS, Ortona L, Cauda R, Fauci AS. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol. 1996 Aug 1;157(3):1271-8.

Shuter J, Hatcher VB, Lowy FD. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996;64:310-8.

 

Click here to log in